@FiercePharma: More Indian hospitals eye anti-Ranbaxy policies, Business Standard reports. Some patients asking to switch. Report | Follow @FiercePharma
@EricPFierce: U.S. arrests 2 Pakistani men for selling controlled substances via the Internet. Interpol tracks them to London. Story | Follow @EricPFierce
@CarlyHFierce: First Ranbaxy, now Wockhardt - what is India to do about its manufacturing problems? Regulators unsure. More | Follow @CarlyHFierce
> Armed with a new approval from European regulators, Gilead Sciences ($GILD) launched its combination HIV pill Stribild in the U.K. and Germany, with Austria, Italy, Spain and the Nordic countries coming soon. Report
> Irish lawmakers passed legislation to introduce reference pricing for drugs and to incentivize use of cheap generics; the measure is expected to take effect next month. Report
> Bayer said U.S. antitrust regulators approved its $1.1 billion acquisition of the contraceptive devices company Conceptus. Report
> Hong Kong's Zuellig Group is selling its Australian pharma wholesaler Symbion to the drug and animal health products company Ebos and will in turn take a 40% stake in the New Zealand company. Report
> India's Cipla posted disappointing results for its fiscal fourth quarter, with sales up 2.4% and net profits down 8%. Report
@FierceMedDev: Luminex re-ups assay deal with Merck KGaA. News | Follow @FierceMedDev
@DamianFierce: Cyberonics slides after CMS again rejects depression device for reimbursement. Article | Follow @DamianFierce
> Teleflex snags CE mark for balloon catheter. More
> CMS declines coverage for Cyberonics' depression device. Story
> Biosensors bets on 15% annual growth thanks to M&A. Article
> Toshiba, TPG said to bid on Panasonic's billion-dollar health biz. Report
Biotech News
@FierceBiotech: GSK buys Okairos (Fierce 15 profile) for $325M, strengthens vaccines biz. Release | Follow @FierceBiotech
@JohnCFierce: Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. News | Follow @JohnCFierce
@RyanMFierce: UPDATED: GlaxoSmithKline bags genetic vaccine developer Okairos for $325M. Article | Follow @RyanMFierce
@EmilyMFierce: University of Alabama begins Parkinson's biomarker study. Story | Follow @EmilyMFierce
> Alexandria lands anchor R&D tenant for San Francisco biotech cluster. Article
> GenVec seeks liquidation after gene therapy setbacks. Report
> Novo spearheads $175M financing to back Ophthotech's PhIII AMD study. More
> Sights set on Asia, Amgen sets up JV development deal with Astellas. News
Biomarkers News
> New CTC technology looks promising to track evolution of prostate cancer. Report
> Swedish team discovers protein common to aggressive bladder cancer. More
> Cenix to collaborate with Debiopharm on predictive biomarkers. Article
> Pancreatitis or cancer? Mayo Clinic says mutated gene points the way. Story
> Johns Hopkins: Two genes help predict postpartum depression risk. Item
Drug Delivery News
@MichaelGFierce: Morphine delivery platform could diminish abuse potential. Item | Follow @MichaelGFierce
> Shape-shifting nanoparticles anchor to tumor cells, deliver drugs. Story
> New drug targets lock-and-key mechanism of prostate cancer growth. Article
> Covidien completes successful drug-coated balloon trial. More
> Inhalable chemo-carrying nanoparticles target lung cancer directly. Report
And Finally... The fight against malaria in Africa has been hobbled by an influx of phony drugs. Report